Olivia “Libby” Morgan, PharmD, BCCCP, BCGP

Every day across hospitals and health systems, pharmacists use their specialized knowledge to improve patient outcomes. They work with physicians, nurses and other healthcare team members to help people make the best use of medicines. Learn more about ways they make a difference: yourpharmacist.org #YourPharmacist

@AANmember #rxtwitter #neurology

Thankful to be a part of @ASHPOfficial campaign spotlighting hospital and clinical pharmacy! 🤩 yourpharmacist.org/stories/olivia… @GradyHealth @EmoryNeurology

Are you Grady Strong? Come join our team as a clinical pharmacist in our neurology clinic! 🧠💊🤩 careers.gradyhealth.org/jobdetails/gmh… #rxtwitter #Neurology #ashp #gradystrong #aanmember

Oof. Maybe the help actually hurts…. Need to discuss this much more #neurology #rxtwitter nejm.org/doi/full/10.10…

What do the @WuTangClan and cervical dissections have in common? 🧠 #Neurology #rxtwitter

We are thrilled to share our Vascular Neurology Fellowship Match Results for 2025-26. Congratulations & welcome to the Emory/Grady Stroke family!

@_lamooooo representing @GradyHealth Neurology at #serc2024 by presenting her migraine research 🧠💊 #neurology #aanmember #gradystrong @EmoryNeurology @katskript

Grady Clinical pharmacy the impact of preprocedural PRUs on bleeding risk in neuroendovascular procedures at #serc2024 #Neurology #gradystrong #gradyhealth

Presentation 5 is done!

#Gradystrong at #serc2024

Another solid presentation for @GradyHealth at #serc2024

@GradyHealth representing at #serc2024. 2 of 12 research presentations down!

According to this study, neither targeted lecanemab treatment nor treatment unrestricted by APOE ε4 genotype is cost-effective vs standard of care alone for patients with mild cognitive impairment or mild dementia due to Alzheimer disease: bit.ly/3IDcJEJ #NeuroTwitter

A narrative review on possible effects of #cannabis, #endocannabinoids, & other lipids in #migraine-related pain finds data from animal models suggesting the endocannabinoid system & CB1 receptor as potential treatment targets …adachejournal.onlinelibrary.wiley.com/doi/10.1111/he… R Greco et al

⁦@Neurdle⁩ is awesome way to have fun and learn 🧠! neurdle.com/description

More than 50 million people live with epilepsy worldwide. A new Review in @TheLancetNeuro discusses causes and diagnostic considerations, highlights the importance of epilepsy classification, and describes emerging investigative tools for diagnosis: hubs.li/Q02thLcr0

@PropofolDreamz Stroke risk is still great despite fall risk link.springer.com/content/pdf/10… Truthfully, while some cases may be different, older data with older drugs suggest falling more than once a day for risk to outweigh benefits ncbi.nlm.nih.gov/pmc/articles/P…

Cardio friends. I’m stupid. Why anticoagulate elderly (>75 yo) pts for afib? If I’m not mistaken, at the highest CHADSVASC, stroke risk is 10-12% at best. Wouldn’t ICH from a fall be more detrimental than AIS that may still be amenable to reperfusion strategies? #EMRx #TwitteRx

🌟 Elevating Stroke Care Since 2010! Our Marcus Stroke and Neuroscience Center team continues to change how stroke is treated in Atlanta and beyond. Congrats on your latest milestone. 🖐️🎤 #AlwaysInnovating